Pro Share Advisors LLC Tenaya Therapeutics, Inc. Transaction History
Pro Share Advisors LLC
- $42.5 Billion
- Q4 2024
A detailed history of Pro Share Advisors LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 15,440 shares of TNYA stock, worth $18,528. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,440
Previous 10,422
48.15%
Holding current value
$18,528
Previous $20,000
10.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TNYA
# of Institutions
86Shares Held
43.7MCall Options Held
74.3KPut Options Held
192K-
Column Group LLC San Francisco, CA9.4MShares$11.3 Million24.12% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$8.08 Million0.83% of portfolio
-
Jpmorgan Chase & CO New York, NY5.16MShares$6.19 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$4.89 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$3.93 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $49.6M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...